You have 0 items in your cart
Mitochondria were once viewed primarily as structures responsible for producing cellular energy.
That view has changed dramatically.
Researchers now know that mitochondria participate in signalling, cellular stress responses and communication with other parts of the cell.
One particularly interesting discovery has been a family of molecules known as mitochondrial-derived peptides, or MDPs.
Among them is SHLP2 — Small Humanin-Like Peptide 2.
SHLP2 is being investigated for its relationships with mitochondrial function, cellular stress, energy regulation, insulin signalling and ageing.
What Is SHLP2?
SHLP2 stands for Small Humanin-Like Peptide 2.
It belongs to a group of six related peptides:
SHLP1, SHLP2, SHLP3, SHLP4, SHLP5 and SHLP6.
Researchers identified these peptides while investigating small open reading frames associated with mitochondrial DNA.
SHLP2 is a short peptide containing 26 amino acids.
Like Humanin, it is associated with the mitochondrial 16S ribosomal RNA region.
Its discovery helped strengthen an important new concept in mitochondrial biology:
Mitochondrial genetic information may encode biologically active signalling molecules that were previously overlooked.
What Are Small Humanin-Like Peptides?
Humanin was the first mitochondrial-derived peptide to attract major scientific attention.
Researchers subsequently searched the same mitochondrial genetic region and identified six additional potential peptides.
They were named Small Humanin-Like Peptides, or SHLPs.
Despite the shared name, the six SHLPs don’t appear to perform identical biological functions.
Experimental studies have found different effects between individual SHLP molecules.
SHLP2 and SHLP3 have received particular attention because early research identified effects involving cellular survival and mitochondrial metabolism.
SHLP2 and Mitochondrial Function
One of the major areas of SHLP2 research concerns mitochondrial performance.
Experimental studies have associated SHLP2 with changes in:
- mitochondrial respiration
- oxygen consumption
- cellular energy metabolism
- mitochondrial biogenesis
- reactive oxygen species
- cellular survival
These findings suggest that SHLP2 could participate in the way cells adapt to metabolic or oxidative stress.
However, most of this research remains experimental.
It is therefore important to distinguish mechanistic findings from demonstrated clinical effects in humans.
What Is Oxidative Stress?
Cells naturally produce reactive oxygen species during normal metabolism.
At controlled levels, these molecules can participate in cellular signalling.
Problems can arise when production exceeds the cell’s antioxidant and repair capacity.
This state is commonly called oxidative stress.
Mitochondria are deeply involved because they’re both a source and a target of reactive oxygen species.
SHLP2 has been investigated in experimental models examining whether mitochondrial-derived peptides influence this balance.
SHLP2 and Cellular Survival
Researchers have also examined SHLP2 in relation to apoptosis.
Apoptosis is the controlled process through which cells initiate programmed cell death.
It’s essential to normal tissue biology, but excessive activation can contribute to cellular damage.
Early studies found that SHLP2 could reduce markers of apoptosis in certain experimental cell models.
This contributed to its classification as a potentially cytoprotective mitochondrial signalling peptide.
Again, cytoprotection observed in laboratory models isn’t equivalent to demonstrating treatment of a human disease.
SHLP2 and Ageing
SHLP2 has also attracted attention in ageing research.
Early human observations reported that circulating SHLP2 concentrations appeared to decline with age. (PubMed)
That finding is particularly interesting because mitochondrial function itself changes throughout ageing.
Researchers studying the biology of ageing increasingly examine processes including:
mitochondrial dysfunction
oxidative stress
cellular senescence
altered nutrient sensing
and loss of cellular resilience.
Mitochondrial-derived peptides potentially connect several of these processes.
SHLP2 and Insulin Signalling
Metabolic research provides another important branch of SHLP2 science.
Experimental work has investigated whether SHLP2 can influence the body’s response to insulin.
In early animal research, centrally administered SHLP2 increased glucose uptake and suppressed hepatic glucose production during specialised metabolic clamp experiments. (PubMed)
This led researchers to investigate SHLP2 as a potential regulator of insulin sensitivity.
However, this remains predominantly mechanistic and preclinical research.
It shouldn’t be interpreted as evidence that SHLP2 is an established treatment for insulin resistance or diabetes.
SHLP2 and Energy Homeostasis
More recent research has attempted to understand how SHLP2 might communicate with the brain.
A particularly interesting study investigated SHLP2 in the hypothalamus — a region involved in regulating energy balance.
In mouse experiments, researchers found that SHLP2 influenced POMC neurons within the arcuate nucleus of the hypothalamus.
The researchers also identified CXCR7 as a potential receptor involved in SHLP2 signalling. (PubMed)
This was important because the receptor responsible for SHLP2’s biological activity had previously been unclear.
What Are POMC Neurons?
POMC stands for proopiomelanocortin.
POMC neurons form part of the brain’s complex network for regulating energy balance and feeding behaviour.
We’ve already encountered this pathway when looking at MC4R research.
This creates an interesting connection between two apparently separate research fields:
mitochondrial signalling
and
central energy regulation.
A mitochondrial-derived peptide may therefore potentially communicate information about cellular energy conditions to neural systems involved in whole-body metabolism.
SHLP2 and CXCR7
CXCR7 is also known as ACKR3 — atypical chemokine receptor 3.
It has been studied in several areas of biology and wasn’t originally identified as a conventional metabolic receptor.
Research suggesting an interaction between SHLP2 and CXCR7 therefore provides another example of how apparently unrelated signalling systems can intersect.
Much more research is required to establish the significance of this pathway in humans.
But mechanistically, it gives scientists a possible explanation for some of SHLP2’s observed biological effects.
SHLP2 and Liver Metabolism
The liver is another emerging area.
A 2026 review of mitochondrial-derived peptides in liver disease highlighted SHLP2’s experimental relationships with mitochondrial function, insulin sensitivity, glucose homeostasis and oxidative stress. (PubMed)
This is particularly interesting because the liver acts as one of the body’s major metabolic control centres.
It processes nutrients, stores and releases glucose, handles lipids and responds to hormonal signals.
Understanding whether mitochondrial peptides participate in this regulation could reveal another layer of metabolic communication.
SHLP2 and Protein Misfolding
Another unusual branch of SHLP2 research concerns protein folding.
Proteins must adopt particular three-dimensional structures to function normally.
Under some circumstances, proteins can misfold and aggregate.
Experimental research has investigated whether SHLP2 possesses chaperone-like activity capable of interacting with misfolded protein species.
One study examined islet amyloid polypeptide, or IAPP, which can form amyloid deposits in pancreatic tissue.
Researchers found that SHLP2 interacted with misfolded IAPP species in laboratory experiments. (PubMed Central (PMC))
This introduces another possible connection between mitochondrial stress responses and cellular protein quality control.
SHLP2 and Neurological Research
Mitochondrial dysfunction is also heavily investigated in neurological disease.
A naturally occurring genetic variant affecting SHLP2 has attracted particular attention in Parkinson’s disease research.
Researchers identified a mitochondrial DNA variant producing a modified form of SHLP2 known as K4R.
Experimental work found that this variant was more stable than conventional SHLP2 and showed protective effects against mitochondrial dysfunction in laboratory and animal models. (PubMed)
This doesn’t establish SHLP2 as a Parkinson’s treatment.
It does, however, demonstrate how naturally occurring mitochondrial genetic variation can alter a mitochondrial-derived peptide.
Humanin vs SHLP2
Humanin and SHLP2 are related mitochondrial-derived peptides, but they shouldn’t be treated as interchangeable.
Both originate from small coding regions associated with mitochondrial 16S rRNA.
Both have been investigated in cellular stress and metabolism.
But their sequences and biological characteristics differ.
SHLP2 has increasingly attracted interest around:
energy homeostasis
insulin signalling
mitochondrial metabolism
hypothalamic signalling
and oxidative stress.
Understanding individual mitochondrial peptides separately is therefore important.
A Hidden Layer of the Mitochondrial Genome
Perhaps the most fascinating part of SHLP2 research isn’t any single experimental effect.
It’s what the peptide tells us about mitochondrial DNA.
For decades, scientists believed they had a relatively complete understanding of what the mitochondrial genome encoded.
The discovery of small open reading frames challenged that assumption.
Tiny genetic sequences that were previously overlooked may produce biologically active molecules.
This has created an emerging research field involving microproteins and mitochondrial-derived peptides.
Why SHLP2 Is Worth Watching
SHLP2 remains an early-stage research subject.
There is a substantial difference between interesting cellular or animal research and demonstrating a safe and effective clinical application in humans.
But the biology itself is compelling.
SHLP2 connects:
mitochondrial genetics
cellular stress
energy metabolism
brain signalling
insulin biology
and ageing research.
It therefore represents something very different from conventional receptor agonists.
Instead of designing another molecule to imitate a familiar metabolic hormone, researchers are uncovering signalling peptides that appear to have been encoded inside mitochondria all along.
And SHLP2 suggests there may still be considerably more hidden biology within the mitochondrial genome waiting to be discovered.
Research Notice: SHLP2 remains an experimental research peptide. Much of the evidence discussed above comes from cellular and animal studies and should not be assumed to represent established effects in humans. This article is provided for scientific and educational purposes only and does not provide medical advice, treatment recommendations or dosing guidance.